2022
DOI: 10.1021/acs.orglett.2c01429
|View full text |Cite
|
Sign up to set email alerts
|

Total Synthesis of (+)-Neopeltolide by the Macrocyclization/Transannular Pyran Cyclization Strategy

Abstract: An 11-step synthesis of (+)-neopeltolide was developed. The C1–C7 carboxylic acid and the C8–C16 alcohol were prepared, each in six steps, from (R)- and (S)-epichlorohydrin, respectively. After esterification, our tandem macrocyclization/transannular pyran cyclization strategy was applied to a stereocontrolled construction of the neopeltolide macrolactone. The side chain was synthesized in six steps from ethyl 4-oxazolecarboxylate through palladium-catalyzed cross-couplings. A Mitsunobu reaction of the neopelt… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
8
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
3
1

Relationship

1
7

Authors

Journals

citations
Cited by 17 publications
(8 citation statements)
references
References 51 publications
0
8
0
Order By: Relevance
“…A much more challenging test is exemplified by the synthesis of the macrocyclic core of (+)-Neopeltolide ( 10 ), a highly cytotoxic marine macrolactone with prominent anticancer properties . The complex structure of this macrolactone, with six stereocenters and a number of oxygen-containing functional groups, represents an appealing target for synthesis. , Previously, we reported the application of (allyl)­tributylstannane 2b as a synthetic equivalent of a C5-bipolar isoprenoid synthon in the synthesis of the C7–C16 building block of (+)-Neopeltolide ( 11 ) (Scheme b) . We anticipated utilizing the same bifunctional building block 2b for the assembly of 2,6- cis -4-hydroxy-THP unit in 10 , thus implementing an iterative biomimetic strategy similar to the biosynthesis of terpenoids.…”
Section: Results and Discussionmentioning
confidence: 99%
“…A much more challenging test is exemplified by the synthesis of the macrocyclic core of (+)-Neopeltolide ( 10 ), a highly cytotoxic marine macrolactone with prominent anticancer properties . The complex structure of this macrolactone, with six stereocenters and a number of oxygen-containing functional groups, represents an appealing target for synthesis. , Previously, we reported the application of (allyl)­tributylstannane 2b as a synthetic equivalent of a C5-bipolar isoprenoid synthon in the synthesis of the C7–C16 building block of (+)-Neopeltolide ( 11 ) (Scheme b) . We anticipated utilizing the same bifunctional building block 2b for the assembly of 2,6- cis -4-hydroxy-THP unit in 10 , thus implementing an iterative biomimetic strategy similar to the biosynthesis of terpenoids.…”
Section: Results and Discussionmentioning
confidence: 99%
“…Then, the absolute stereochemistry of 1 was stablished after the first total synthesis of 1 reported independently by the groups of Panek [13] and Scheidt [14] in 2007 and 2008, respectively. The total synthesis of (+)-neopeltolide (1) was reported recently, in 2022, by Fuwa et al [15]. Neopeltolide ( 1) is an inhibitor of the in vitro proliferation of the A-549 adenocarcinoma of the human lung (IC 50 = 1.2 nM), the NCI-ADR-RES human ovary sarcoma (IC 50 = 5.1 nM), and the P388 murine leukemia cell lines (IC 50 = 0.56 nM).…”
Section: Introductionmentioning
confidence: 91%
“…1,2 The high reactivity of the three-membered ring provides the use of ECH to obtain di-and trifunctional organic compounds, polyfunctional polymers, and composites based on them 2,3 to develop effective methods for the synthesis of new heterocyclic and macrocyclic molecules. [4][5][6][7][8][9] The reactions of epichlorohydrin with proton-containing reagents (carboxylic acids, alcohols, phenols) are widely used for the synthesis of biologically active substances that exhibit antibacterial, antituberculous, and antimalarial properties, act as antioxidants and enzyme inhibitors, and are included to hypoglycemic drugs. 1,[10][11][12] The oxirane ring opening by carboxylic acids occurs to form two regioisomeric chlorohydrin esters (Scheme 1).…”
Section: Introductionmentioning
confidence: 99%